Results 81 to 90 of about 15,000 (182)

Cross-platform transcriptomic profiling of the response to recombinant human erythropoietin. [PDF]

Sci Rep, 2021
Wang G, Kitaoka T, Crawford A, Mao Q, Hesketh A, Guppy FM, Ash GI, Liu J, Gerstein MB, Pitsiladis YP.   +9 more
europepmc   +1 more source

Sensitive Analysis of Recombinant Human Erythropoietin Glycopeptides by On-Line Phenylboronic Acid Solid-Phase Extraction Capillary Electrophoresis Mass Spectrometry. [PDF]

J Proteome Res, 2023
Mancera-Arteu M, Benavente F, Sanz-Nebot V, Giménez E.   +3 more
europepmc   +1 more source

Evaluation of recombinant human erythropoietin responsiveness by measuring erythrocyte creatine content in haemodialysis patients. [PDF]

BMC Nephrol, 2021
Hasegawa S, Nakamura S, Sugiura T, Tsuka Y, Takahashi N, Matsumura K, Okumiya T, Baden M, Shiojima I.   +8 more
europepmc   +1 more source

Further Evidence of Neuroprotective Effects of Recombinant Human Erythropoietin and Growth Hormone in Hypoxic Brain Injury in Neonatal Mice. [PDF]

Int J Mol Sci, 2022
Klepper S, Jung S, Dittmann L, Geppert CI, Hartmann A, Beier N, Trollmann R.   +6 more
europepmc   +1 more source

[Human recombinant erythropoietin therapy].

Medicina, 2006
Recombinant human erythropoietin (rHuEpo) has become the most widely used cytokine in the world. Following the success of its use in patients with end-stage renal disease, the usefulness of rHuEpo to ameliorate other anemias was assessed, including pediatric patients and newborn infants.
Hugo, Donato, Hugo, Ferro
openaire   +1 more source

Recombinant human erythropoietin ameliorates cognitive dysfunction of APP/PS1 mice by attenuating neuron apoptosis via HSP90β. [PDF]

Signal Transduct Target Ther, 2022
Wan HL, Zhang BG, Chen C, Liu Q, Li T, He Y, Xie Y, Yang X, Wang JZ, Liu GP.   +9 more
europepmc   +1 more source

Comparison of risk of peritoneal dialysis-associated peritonitis between roxadustat and recombinant human erythropoietin in peritoneal dialysis patients: a retrospective comparative cohort study. [PDF]

Ann Transl Med, 2022
Zhang W, Tan Y, Ai J, Luo F, Su X, Wu Q, Su L, Pan J, Zheng Q, Li B, Chen J, Luo Q, Chen J, Dou X.   +13 more
europepmc   +1 more source

Unexpected Beneficial Response to Etanercept Therapy in a Hemodialysis Patient with Ankylosing Spondylitis

Turkish Journal of Nephrology, 2019
Erythropoietin (EPO) defi ciency is the main cause of renal anemia. However, chronic infl ammation may be one of the important causes for EPO resistance in patients with renal anemia.
Mehmet Tuğrul SEZER, Mehmet ŞAHİN, Atila ALTUNTAŞ   +2 more
doaj  

Case report: Dynamic antibody monitoring in a case of anti-recombinant human erythropoietin-mediated pure red cell aplasia with prolonged course after kidney transplantation. [PDF]

Front Immunol, 2022
Chen XM, Li H, Wu Y, Wang LL, Bai YJ, Shi YY.   +5 more
europepmc   +1 more source

OSTEOINDUCTIVE FACTORS FOR TREATMENT OF LONG-BONE NONUNION FRACTURES IN DOGS AND CATS

Bulgarian Journal of Veterinary Medicine
Bone nonunion is defined as the body’s inability to heal a fracture. It is a serious complication that may occur when fracture instability, impaired blood supply or infection are present.
R. Vasileva
doaj   +1 more source